Clinicians and researchers lack clear diagnostic thresholds for prion disease detection and risk assessment

Medical professionals struggle to determine infectious prion protein (PrP) concentration levels that reliably indicate prion disease risk, making early diagnosis and patient stratification extremely difficult. Current diagnostic methods lack standardized quantitative benchmarks, forcing clinicians to make treatment and monitoring decisions with incomplete information. This uncertainty delays intervention, increases misdiagnosis rates, and leaves patients and families without clear risk communication.